{
    "clinical_study": {
        "@rank": "16717", 
        "arm_group": {
            "arm_group_label": "Rectal Cancer Patients", 
            "description": "Patients with a diagnosis adenocarcinoma of the rectum will provide a tumor sample from their diagnostic biopsy and surgical procedure for research purposes, including RNA gene expression analysis.  In addition to a standard MRI, patients will have an Intravoxel Incoherent Motion MRI (IVIM) and a Dynamic Contrast Enhanced MRI (DCE-MRI) for research purposes."
        }, 
        "biospec_descr": {
            "textblock": "Patients who enroll in the study will all undergo proctoscopy, as part of their standard of\n      care evaluation of their rectal mass. Biopsies will be obtained at the time of proctoscopy\n      and samples will be sent to pathology for paraffin embedded blocks for diagnostic evaluation\n      and for subsequent research. Patients will also have tissue stored in RNA later for\n      subsequent microarray analysis."
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "This is an observational study of tumor samples and MRI imaging in patients with rectal\n      cancer.  Patients who agree to participate will allow a sample of their tumor and their MRI\n      scans to be used for research purposes to see if it is possible to predict patients'\n      response to standard treatment for rectal cancer."
        }, 
        "brief_title": "Immunoscore in Rectal Cancer", 
        "completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Cancer of the Rectum", 
            "Neoplasms, Rectal", 
            "Rectal Cancer", 
            "Rectal Tumors", 
            "Rectal Adenocarcinoma"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Adenocarcinoma", 
                "Neoplasms", 
                "Rectal Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "The quality of the immune environment in colorectal cancer biopsy samples correlates with\n      disease-free survival and overall survival more so than current staging conventions.  This\n      study will use a scoring system called 'immunoscore' to characterize the immune enviroment.\n      Researchers hypothesize that the immunoscore will correlate with outcomes of patients\n      treated with neoadjuvant chemoradiation."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with a diagnosis of a rectal mass suspicious for or known to be an\n             adenocarcinoma of the rectum.\n\n          -  Age > 18\n\n          -  Ability to give informed consent and comply with the protocol. Patients with a\n             history of psychiatric illness must be judged able to understand fully the\n             investigational nature of the study and the risks associated with the therapy.\n\n        Exclusion Criteria:\n\n          -  History of other malignancy in the past 2 years except carcinoma in situ of the\n             cervix or bladder, or non-melanomatous skin cancer\n\n          -  Other medical or psychiatric conditions that in the opinion of the Principal\n             Investigator would preclude safe participation in protocol."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with a diagnosis of a rectal mass suspicious for or known to be an adenocarcinoma\n        of the rectum."
            }
        }, 
        "enrollment": {
            "#text": "86", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02017509", 
            "org_study_id": "13-107A"
        }, 
        "intervention": [
            {
                "arm_group_label": "Rectal Cancer Patients", 
                "description": "A tumor sample from the diagnostic biopsy and surgical procedure will be used for research.", 
                "intervention_name": "Diagnostic Biopsy and Surgical Procedure", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Rectal Cancer Patients", 
                "description": "At the end of a standard MRI, we will perform IVIM, which is a diffusion-weighted imaging sequence that simultaneously characterizes the microscopic diffusivity of water and the macroscopic transport of water via bulk flow.  IVIM may more accurately reflect the properties of the tumor microenvironment including vascular permeability, interstitial fluid pressure, and response to neoadjuvant therapy.", 
                "intervention_name": "Intravoxel incoherent motion MRI (IVIM)", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Rectal Cancer Patients", 
                "description": "Following a standard MRI scan, Dynamic Contrast Enhanced MRI (DCE-MRI) will be done.  DCE-MRI is an indicator-dilution experiment in which the delivery and transcapillary transfer of a contrast agent, typically one of a number of gadolinium-based contrast agents (GBCA), is used to assess a number of parameters characterizing tissue physiology. In locally advanced rectal cancer patients, use of DCE-MRI for determining pathologic response has produced equivocal results but more promising data has been published recently in the cervical cancer literature.", 
                "intervention_name": "Dynamic Contrast Enhanced MRI (DCE-MRI)", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Rectal Cancer Patients", 
                "description": "RNA will be collected from biopsy and surgical tissue for gene expression analysis.", 
                "intervention_name": "RNA gene expression analysis", 
                "intervention_type": "Genetic"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Immunophenotype", 
            "Immunoscore", 
            "MRI", 
            "RNA Later"
        ], 
        "lastchanged_date": "December 16, 2013", 
        "link": {
            "description": "Providence Cancer Center", 
            "url": "http://oregon.providence.org/patients/programs/providence-cancer-center/Pages/default.aspx"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Portland", 
                        "country": "United States", 
                        "state": "Oregon", 
                        "zip": "97213"
                    }, 
                    "name": "Providence Health & Services"
                }, 
                "investigator": [
                    {
                        "last_name": "Alexandru Bageac, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Carlo Bifulco, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Todd Crocenzi, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Brendan Curti, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Bernard Fox, PhD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Walter Urba, MD, PhD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Mark Whiteford, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "youngkri@ohsu.edu", 
                    "last_name": "Kristina Young, MD, PhD", 
                    "phone": "503-418-0990"
                }, 
                "facility": {
                    "address": {
                        "city": "Portland", 
                        "country": "United States", 
                        "state": "Oregon", 
                        "zip": "97239"
                    }, 
                    "name": "Oregon Health & Science University"
                }, 
                "investigator": [
                    {
                        "last_name": "Bryan Foster, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Charles Thomas, Jr., MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Kristina Young, MD, PhD", 
                        "role": "Principal Investigator"
                    }
                ], 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Study to Determine the Immunopheotype of Locally Advanced Rectal Adenocarcinoma and Its Correlation With the Efficacy of Neoadjuvant Chemoradiotherapy", 
        "overall_contact": {
            "email": "marka.crittenden@providence.org", 
            "last_name": "Marka Crittenden, MD, PhD", 
            "phone": "(503) 215-6029"
        }, 
        "overall_contact_backup": {
            "email": "brenda.fisher@providence.org", 
            "last_name": "Brenda Fisher, RN", 
            "phone": "503-215-2613"
        }, 
        "overall_official": {
            "affiliation": "Earle A. Chiles Research Institute at Providence Health & Services", 
            "last_name": "Marka Crittenden, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Office for Human Subjects Protections", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Quantitative immunohistochemical analysis will be performed on parameters of interest on both pre-treatment biopsy specimens as well as post-operative specimens.  The pre-treatment sample will be used to establish the immunophenotype score. The primary analysis will evaluate the ability of immunophenotype score to correlate with pathologic response.", 
            "measure": "Correlation of the number of infiltrating leukocytes within a biopsy sample with pathologic response", 
            "safety_issue": "No", 
            "time_frame": "16 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02017509"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Providence Health & Services", 
        "sponsors": {
            "collaborator": {
                "agency": "Oregon Health and Science University", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Providence Health & Services", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "December 2013"
    }
}